Key terms
About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest JNJ news
Yesterday
7:07am ET
Clearside Biomedical appoints Chong as Chief Medical Officer
Yesterday
6:50am ET
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Aveanna Healthcare Holdings (AVAH)
Mar 15
3:17pm ET
Legend Biotech notes ODAC recommends Carvykti for earlier treatment of myeloma
Mar 15
3:03pm ET
J&J says ODAC recommends Carvykti for earlier treatment of myeloma
Mar 15
12:51pm ET
FDA advisors vote in favor of expanding label of J&J’s Carvykti
Mar 15
12:03pm ET
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
Mar 14
12:15am ET
Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald
Mar 13
8:04am ET
Foot Locker appoints Cindy Carlisle as Chief Human Resources Officer
Mar 08
8:57am ET
Neumora Therapeutics price target raised to $31 from $24 at RBC Capital
Mar 07
2:15pm ET
Johnson & Johnson put volume heavy and directionally bearish
Mar 06
1:22pm ET
Ambrx Biopharma shareholders approve acquisition by Johnson & Johnson
Mar 06
10:07am ET
High Benzene Levels Found in Multiple Brands’ Acne Treatments
Mar 06
9:43am ET
J&J unit applies for Darzalex quadruplet therapy in Europe
Mar 06
9:20am ET
Lab says chemical linked to cancer found in acne creams, Bloomberg reports
Mar 01
4:00pm ET
Johnson & Johnson says Rybrevant-chemotherapy combo approved by FDA
Feb 29
6:32am ET
Barclays Keeps Their Hold Rating on Johnson & Johnson (JNJ)
Feb 28
7:23am ET
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Masimo (MASI) and Johnson & Johnson (JNJ)
Feb 28
5:38am ET
Hold Rating on Johnson & Johnson Amid Anticipated Varipulse Approval and Afib Market Dynamics
Feb 23
7:23am ET
Legend Biotech gets CHMP recommendation for expansion of Carvykti label
Feb 21
7:25am ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 21
4:55am ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 21
3:20am ET
Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)
Feb 20
4:28pm ET
Johnson & Johnson: FDA approves sBLA for TECVAYLI for reduced dosing frequency
Feb 20
8:14am ET
Genmab price target lowered to $50 from $54 at Truist
Feb 15
12:57pm ET
BTIG medical technology analyst to hold analyst/industry conference call
Feb 15
9:40am ET
Unusually active option classes on open February 15th
Feb 14
9:05pm ET
Buy Rating Justified by Johnson & Johnson’s Strong Performance and Growth Prospects
Feb 14
3:34pm ET
Johnson & Johnson (NYSE:JNJ) Slips Despite New Frostbite Treatment
Feb 12
12:28pm ET
J&J lawsuit may spur adoption of GoodRx program, says Citi
Feb 08
9:45am ET
Senate Health, Education, Labor & Pensions Committee holds a hearing
Feb 08
6:13am ET
Pharmaceutical CEOs are set to testify on drug prices, NY Times reports
Mar 16
8:15am ET
Meet the "Magnificent Seven" Stock That Pays More Dividends Than Any Other U.S.-Based Company
Mar 16
3:55am ET
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
Mar 13
5:21am ET
3 No-Brainer Stocks to Buy With $300 Right Now
Mar 12
6:53am ET
2 High-Yield Dow Jones Dividend Stocks to Buy Now and Hold Forever
Mar 11
5:35am ET
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
No recent press releases are available for JNJ
JNJ Financials
Key terms
Ad Feedback
JNJ Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
JNJ Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range